The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex several-stage synthetic process. Preliminary routes focused on amino acid chain fragment coupling, https://aliciaoaup011908.actoblog.com/41578795/synthesis-and-study-applications-of-retatrutide